Gary Globe
Overview
Explore the profile of Gary Globe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Di Tanna G, Bychenkova A, ONeill F, Wirtz H, Miller P, Hartaigh B, et al.
Pharmacoeconomics
. 2019 Jan;
37(3):359-389.
PMID: 30596210
Background: Heart failure (HF) is a well-recognized public health concern and imposes high economic and societal costs. Decision analytic models exist for evaluating the economic ramifications associated with HF. Despite...
12.
Whalley D, Globe G, Crawford R, Doward L, Tafesse E, Brazier J, et al.
Health Qual Life Outcomes
. 2018 Aug;
16(1):160.
PMID: 30075729
Background: The increasing emphasis on patient-reported outcomes in health care decision making has prompted greater rigor in the evidence to support the instruments used. Acceptability and content validity are important...
13.
Higgins P, Harding G, Revicki D, Globe G, Patrick D, Fitzgerald K, et al.
J Patient Rep Outcomes
. 2018 Jun;
2(1):26.
PMID: 29888745
Background: The clinical course of ulcerative colitis (UC) and the effects of treatment are assessed through patient-reported signs and symptoms (S&S), and endoscopic evidence of inflammation. The Ulcerative Colitis Patient-Reported...
14.
Higgins P, Harding G, Leidy N, DeBusk K, Patrick D, Viswanathan H, et al.
J Patient Rep Outcomes
. 2018 May;
2(1):24.
PMID: 29770803
Background: The clinical course of Crohn's disease (CD) and the effect of its treatment are monitored through patient-reported signs and symptoms (S&S), and endoscopic evidence of inflammation. The Crohn's Disease...
15.
Sullivan P, Ghushchyan V, Globe G
J Asthma
. 2017 Oct;
55(9):1002-1010.
PMID: 28976789
Background: Asthma control is the main focus of treatment guidelines. Valid instruments such as the Asthma Control Questionnaire (ACQ) require prospective survey. These surveys may be challenging for large population...
16.
Sullivan P, Ghushchyan V, Globe G, Schatz M
J Allergy Clin Immunol
. 2017 May;
141(1):110-116.e7.
PMID: 28456623
Background: Significant adverse effects (AEs) have been associated with continuous exposure to oral corticosteroids (OCSs). The potential association with intermittent exposure is unknown. Objective: We sought to assess the association...
17.
Sullivan P, Ghushchyan V, Globe G, Sucher B
Qual Life Res
. 2016 Oct;
26(4):1037-1058.
PMID: 27757775
Background: Systemic corticosteroids (SCS) are commonly used but are associated with adverse effects. Given their prevalent use, the potential impact of SCS use on health-related quality of life (HRQoL) is...
18.
Sullivan P, Globe G, Ghushchyan V, Campbell J, Bender B, Magid D
Ann Allergy Asthma Immunol
. 2016 Sep;
117(3):251-257.e2.
PMID: 27613458
Background: Understanding the effect of worsening asthma control on expenditures and health resource utilization (HRU) is important. Objective: To explore the association of economic outcomes with asthma control cutoffs and...
19.
Globe G, Currie B, Leidy N, Jones P, Mannino D, Martinez F, et al.
Health Qual Life Outcomes
. 2016 Jul;
14(1):104.
PMID: 27424173
Background: The morning tends to be the most difficult time of day for many patients with chronic obstructive pulmonary disease (COPD) when symptoms can limit one's ability to perform even...
20.
Sullivan P, Ghushchyan V, Campbell J, Globe G, Bender B, Magid D
Qual Life Res
. 2016 Jul;
25(12):3017-3026.
PMID: 27387417
Background: Accurate assessment of preference-based health-related quality of life is important in determining the value of asthma interventions. Objective: To examine the sensitivity and responsiveness of the EQ-5D and the...